BridgeBio Pharma, Inc. (BBIO) Earnings
NASDAQ·Healthcare·Biotechnology
$69.59
-6.62%
Mkt Cap $14.77B
Next Earnings
In 6 daysTue, May 5, 2026
EPS Estimate
-$0.71
12 analysts
Revenue Estimate
$178.00M
Last quarter: missed by -40.17% on EPS, +5.00% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$14.77B
P/E
—
Fwd P/E
—
P/S
29.41
Rev TTM
—
EPS TTM
-$3.79